Cargando…

36例T细胞淋巴瘤患者一线应用沙利度胺治疗的临床分析

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348338/
https://www.ncbi.nlm.nih.gov/pubmed/27431083
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.06.019
_version_ 1783556794346373120
collection PubMed
description
format Online
Article
Text
id pubmed-7348338
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Editorial office of Chinese Journal of Hematology
record_format MEDLINE/PubMed
spelling pubmed-73483382020-07-16 36例T细胞淋巴瘤患者一线应用沙利度胺治疗的临床分析 Zhonghua Xue Ye Xue Za Zhi 短篇论著 Editorial office of Chinese Journal of Hematology 2016-06 /pmc/articles/PMC7348338/ /pubmed/27431083 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.06.019 Text en 2016年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal.
spellingShingle 短篇论著
36例T细胞淋巴瘤患者一线应用沙利度胺治疗的临床分析
title 36例T细胞淋巴瘤患者一线应用沙利度胺治疗的临床分析
title_full 36例T细胞淋巴瘤患者一线应用沙利度胺治疗的临床分析
title_fullStr 36例T细胞淋巴瘤患者一线应用沙利度胺治疗的临床分析
title_full_unstemmed 36例T细胞淋巴瘤患者一线应用沙利度胺治疗的临床分析
title_short 36例T细胞淋巴瘤患者一线应用沙利度胺治疗的临床分析
title_sort 36例t细胞淋巴瘤患者一线应用沙利度胺治疗的临床分析
topic 短篇论著
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348338/
https://www.ncbi.nlm.nih.gov/pubmed/27431083
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.06.019
work_keys_str_mv AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī
AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī
AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī
AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī
AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī
AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī
AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī
AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī
AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī
AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī
AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī
AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī
AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī
AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī
AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī
AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī
AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī
AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī